These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16545073)

  • 21. Inhibition of nitric oxide-dependent activation of soluble guanylyl cyclase by the antimalarial drug, artemisinin.
    Severina IS; Pyatakova NV; Bussygina OG; Mikhailitsyn FS; Khropov YV
    Eur J Pharmacol; 2002 Mar; 438(1-2):69-73. PubMed ID: 11906712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of purified soluble guanylate cyclase by protoporphyrin IX.
    Ignarro LJ; Wood KS; Wolin MS
    Proc Natl Acad Sci U S A; 1982 May; 79(9):2870-3. PubMed ID: 6123998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide.
    Hoenicka M; Becker EM; Apeler H; Sirichoke T; Schröder H; Gerzer R; Stasch JP
    J Mol Med (Berl); 1999 Jan; 77(1):14-23. PubMed ID: 9930922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Soluble forms of guanylate cyclases: mechanism of activation by nitrogen oxide and role in platelet aggregation].
    Severina IS
    Vestn Ross Akad Med Nauk; 1995; (2):41-6. PubMed ID: 7756930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1.
    Martin NI; Derbyshire ER; Marletta MA
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4938-41. PubMed ID: 17587571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation and characterization of a stable soluble guanylate cyclase-overexpressing CHO cell line.
    Becker EM; Wunder F; Kast R; Robyr C; Hoenicka M; Gerzer R; Schröder H; Stasch JP
    Nitric Oxide; 1999; 3(1):55-66. PubMed ID: 10355896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide independent activation of guanylate cyclase by YC-1 causes erectile responses in the rat.
    Mizusawa H; Hedlund P; Brioni JD; Sullivan JP; Andersson KE
    J Urol; 2002 May; 167(5):2276-81. PubMed ID: 11956492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits the spontaneous contractions of isolated pregnant rat myometrium.
    Cetin A; Kaya T; Demirkoprulu N; Karadas B; Duran B; Cetin M
    J Pharmacol Sci; 2004 Jan; 94(1):19-24. PubMed ID: 14745113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells.
    Schmidt K; Schrammel A; Koesling D; Mayer B
    Mol Pharmacol; 2001 Feb; 59(2):220-4. PubMed ID: 11160856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of YC-1-induced activation of soluble guanylyl cyclase.
    Friebe A; Koesling D
    Mol Pharmacol; 1998 Jan; 53(1):123-7. PubMed ID: 9443939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase in activating ability of human platelet guanylate cyclase during aggregation.
    Severina IS; Belushkina NN
    Biochem Int; 1992 Dec; 28(4):621-31. PubMed ID: 1362351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of soluble guanylate cyclase in dilator responses of the cerebral microcirculation.
    Faraci FM; Sobey CG
    Brain Res; 1999 Mar; 821(2):368-73. PubMed ID: 10064823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
    Teng CM; Wu CC; Ko FN; Lee FY; Kuo SC
    Eur J Pharmacol; 1997 Feb; 320(2-3):161-6. PubMed ID: 9059849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway.
    Hwang TL; Hung HW; Kao SH; Teng CM; Wu CC; Cheng SJ
    Mol Pharmacol; 2003 Dec; 64(6):1419-27. PubMed ID: 14645672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Potentiation of NO-dependent activation of soluble guanylyl cyclase by 5-nitroisatin and antiviral preparatation arbidol].
    Severina IS; Shchegolev AIu; Medvedev AE
    Biomed Khim; 2013; 59(3):295-304. PubMed ID: 23987067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
    Wegener JW; Gath I; Förstermann U; Nawrath H
    Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate.
    Homer KL; Wanstall JC
    Br J Pharmacol; 2002 Dec; 137(7):1071-81. PubMed ID: 12429580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble guanylate cyclase of platelets: function and regulation in normal and pathological states.
    Severina IS
    Adv Enzyme Regul; 1992; 32():35-56. PubMed ID: 1353937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.